A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus (clinicaltrials.gov) - Jul 14, 2026 - P1 | N=3 | Completed | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Recruiting ➔ Completed | N=12 ➔ 3 | Trial completion date: Aug 2026 ➔ May 2026
Enrollment change • Trial completion • Trial completion date • Cytomegalovirus Infection • Infectious Disease
|